Metformin and PCOS in Canada: Guidelines, Access, Coverage
The 2023 International PCOS Guideline discusses metformin for PCOS as an option Canadian clinicians may consider alongside lifestyle care, particularly where insulin resistance or other metabolic features are prominent. It's positioned as an adjunct, not a first-line therapy. Lifestyle change (nutrition, activity, sleep) remains the guideline's strongest recommendation for PCOS overall, with prescription options layered on top only when a clinician judges them appropriate. Metformin itself is a long-established, insulin-sensitizing medication listed on Health Canada's Prescription Drug List, so it requires a prescription from a licensed clinician and can't be obtained through an online quiz or program. Most Canadian provincial and private drug plans cover it broadly, without the special-authorization barriers that apply to newer medications. Ongoing use typically involves periodic kidney-function and vitamin B12 monitoring, and the most common early side effects are gastrointestinal, usually easing with a gradual dose increase or the extended-release form. It isn't a weight-loss medication and it isn't a cure for PCOS. It's one option among several within the broader PCOS treatment framework, weighed against your labs, symptoms, and goals. For the metabolic mechanism behind why it comes up at all, see our insulin resistance guide.
Naming note: In May 2026, PCOS was formally renamed polyendocrine metabolic ovarian syndrome (PMOS) by global consensus published in The Lancet. The same 2023 international guideline referenced throughout this article was updated to reflect it. The prescribing and monitoring information here applies identically under both names; see our PCOS-to-PMOS explainer for the rename context. This article uses "PCOS" because that remains the term most patients are searching for during the transition period.
What this page covers
If a clinician has mentioned a prescription option for your PCOS care, or you've seen one discussed in guideline coverage, you probably have practical questions before anything else: what the guideline actually says, whether it needs a prescription, what it costs, and what monitoring looks like. This page answers those questions in plain language, sourced from the guideline and Canadian prescribing references, not general internet claims. For the full picture beyond this one option, start at our PCOS resource hub.
None of this replaces a conversation with your family physician, OB-GYN, or endocrinologist. Prescription decisions in PCOS care are individual, and this page is background for that conversation, not a substitute for it.
Take the free 3-minute quiz
What is metformin, and how does the 2023 guideline discuss it for PCOS?
Metformin is an insulin-sensitizing medication that has been used in Canadian clinical practice for decades, most commonly for type 2 diabetes. In plain terms, it reduces how much glucose the liver releases into the bloodstream and helps the body's cells respond better to the insulin already circulating. It's a well-studied, long-established, generic medication, not a new or experimental one.
Insulin resistance is a common feature of PCOS, present in a large share of women with the condition at any body weight, which is the main reason metformin comes up in PCOS conversations at all. The 2023 International Evidence-Based Guideline for the Assessment and Management of PCOS, developed by Monash University with dozens of partner medical societies, positions metformin as an adjunct, not a first-line therapy. Lifestyle change (nutrition, activity, sleep, behavioural support) remains the guideline's first-line recommendation for PCOS overall; see our full PCOS treatment framework for how that layered approach works.
Within that framework, the guideline discusses metformin as an option clinicians may consider on top of lifestyle care, particularly where insulin resistance or other metabolic features (elevated BMI, glucose intolerance, a family history of type 2 diabetes) are a significant part of the clinical picture. Recent clinical reviews describe its role as most established for metabolic outcomes, with more variable results for reproductive outcomes like ovulation. See our insulin resistance guide for how that metabolic picture typically gets assessed.
Is metformin used for PCOS in Canada?
Yes. Metformin is one of the more commonly discussed prescription options in Canadian PCOS care, largely because of how often insulin resistance shows up alongside the condition. That said, "commonly discussed" doesn't mean automatic — plenty of Canadians manage their PCOS well without ever being prescribed it, especially when metabolic features aren't the dominant part of their picture.
Whether metformin fits into your care depends on your labs, your symptoms, your goals (metabolic, reproductive, or both), and your clinician's individual read of the guideline framework applied to your case. There's no universal answer, and no page, including this one, can substitute for that individualized assessment.
Prescription, access, and provincial coverage in Canada
Metformin is listed on Health Canada's Prescription Drug List, so it can only be dispensed with a prescription from a licensed practitioner, typically a family physician, endocrinologist, or OB-GYN in the PCOS context. It isn't available over the counter, and no app, quiz, or online program can prescribe it on its own.
That prescription decision rests on a clinical assessment: your history, your labs (kidney function in particular — more on that below), other medications you're taking, and whether the guideline's positioning fits your specific picture. If you're wondering whether it might apply to you, that conversation starts with your own prescribing clinician.
On coverage: metformin has been a generic medication for a long time, which keeps its list price low relative to most prescription categories. Most provincial drug formularies across Canada list it without the special-authorization steps that apply to newer or pricier medications, and private extended-health plans typically cover it as well. Coverage specifics (deductibles, co-pays, whether a PCOS-specific indication is required versus a general metabolic one) vary by province and by plan. Your pharmacist is usually the fastest way to get a real answer for your specific situation.
What monitoring is involved with metformin?
Two things come up most often in the Diabetes Canada clinical practice guideline, which covers metformin monitoring in detail even though it's written primarily for diabetes care:
- Kidney function. Metformin is processed by the kidneys, so clinicians typically check estimated glomerular filtration rate (eGFR) before starting and periodically afterward. Dosing gets adjusted, or the medication gets held or stopped, as kidney function changes.
- Vitamin B12. Long-term metformin use can reduce how well the body absorbs B12, so baseline and periodic B12 checks are a standard part of ongoing monitoring, particularly for people on it for a year or more.
Your prescribing clinician sets the actual monitoring schedule and interval based on your labs and history. What's above describes what generally gets checked, not a fixed calendar that applies to everyone.
What to expect: tolerability
The most common early experience with metformin is gastrointestinal — nausea, bloating, loose stools, or general stomach upset in the first days or weeks. The Diabetes Canada guideline recommends starting at a low dose and increasing it gradually specifically to reduce this, and most people find the initial effects fade within a few weeks as the body adjusts.
An extended-release version exists and is commonly used because it tends to sit more gently on the stomach than the immediate-release version, particularly for people who don't tolerate the standard formulation well. Taking it with food also helps for most people. None of this is guesswork a clinician has to figure out fresh each time. It's a well-worn part of how metformin gets started in Canadian practice.
Who metformin is generally not right for
Metformin isn't appropriate for everyone, and a clinician screens for this before prescribing. It's generally avoided, or used with extra caution, for people with significant kidney impairment, significant liver disease, or a history of reactions requiring metformin to be paused around contrast-dye imaging procedures. People who have persistent gastrointestinal intolerance even after a slow dose increase and a switch to the extended-release form may also be steered toward a different plan.
It's also worth being direct about what metformin is not: it isn't a cure for PCOS, and on its own, it's a modest piece of a much larger picture. The guideline's strongest recommendation for PCOS overall is still lifestyle change (nutrition, activity, sleep), and metformin, where a clinician includes it, sits on top of that foundation rather than replacing it. Pregnancy, nursing, and other individual circumstances are also part of what a clinician weighs, and that assessment happens case by case, not on a page like this one.
Questions worth asking your clinician
If metformin comes up in a conversation about your PCOS care, a few questions can help you understand where it fits and make a shared decision that reflects your situation:
- What part of my picture would this be addressing? Understanding whether the goal is metabolic (insulin resistance, glucose markers), reproductive, or both helps set realistic expectations for what any single option can and can't do.
- Where does it sit relative to the lifestyle plan? The guideline treats nutrition, activity, and sleep as the foundation, so it's fair to ask how a prescription option is meant to work alongside those rather than in place of them.
- What monitoring will I need, and how often? Kidney-function and vitamin B12 checks are standard with metformin, and knowing the schedule up front makes the plan easier to stick with.
- What are my options if I don't tolerate it? A slower dose increase, the extended-release form, or a different approach entirely are all on the table, and it helps to know the plan B before you start.
- Is it covered under my drug plan? Your clinician or pharmacist can confirm coverage and any co-pay so cost isn't a surprise later.
There are no wrong questions here. A good clinician expects them, and the answers are part of how an individualized plan actually gets built.
How Cloudcure approaches PCOS care
Cloudcure's PCOS care program is built around coordinated, guideline-anchored care rather than a single intervention. That starts with a baseline metabolic workup (HbA1c, fasting insulin, a lipid panel, and a free-androgen-index calculation where appropriate) so you and your clinician have real numbers to work from, not guesses.
From there, care runs on a 12-month arc with monthly clinician follow-up and lab reviews at set intervals, built around the nutrition, activity, and behavioural principles the international guideline treats as first-line. When a prescription option is part of the conversation, that decision is made individually with a licensed clinician as part of the program, never as a default, and never separate from the lifestyle work underneath it.
Cloudcure works alongside your family physician, OB-GYN, or endocrinologist, not instead of them — we run the ongoing metabolic arc most primary-care visits don't have the time for. The membership is $99/month and HSA- and HCSA-eligible across major Canadian benefits providers.
See if Cloudcure is right for you
The bottom line
Metformin is a long-established, prescription-only, insulin-sensitizing medication that the 2023 international PCOS guideline discusses as an adjunct: layered on top of lifestyle care, not a replacement for it, and considered mainly where insulin resistance or metabolic features are prominent. It's broadly covered by Canadian provincial and private drug plans, requires periodic kidney-function and B12 monitoring, and comes with well-known, usually manageable gastrointestinal effects early on. Whether it fits your PCOS care is a decision for you and your prescribing clinician, built on your labs and your goals, not something any single page, including this one, can answer for you.